Host defence against infection requires a range of innate and adaptive immune responses that may lead to tissue damage. Such immune-mediated pathologies can be controlled with appropriate T regulatory (Treg) activity. The aim of the present study was to determine the influence of gut microbiota composition on Treg cellular activity and NF-κB activation associated with infection. Mice consumed the commensal microbe Bifidobacterium infantis 35624 followed by infection with Salmonella typhimurium or injection with LPS. In vivo NF-κB activation was quantified using biophotonic imaging. CD4+CD25+Foxp3+ T cell phenotypes and cytokine levels were assessed using flow cytometry while CD4+ T cells were isolated using magnetic beads for adoptive transfer to naïve animals. In vivo imaging revealed profound inhibition of infection and LPS induced NF-κB activity that preceded a reduction in S. typhimurium numbers and murine sickness behaviour scores in B. infantis–fed mice. In addition, pro-inflammatory cytokine secretion, T cell proliferation, and dendritic cell co-stimulatory molecule expression were significantly reduced. In contrast, CD4+CD25+Foxp3+ T cell numbers were significantly increased in the mucosa and spleen of mice fed B. infantis. Adoptive transfer of CD4+CD25+ T cells transferred the NF-κB inhibitory activity. Consumption of a single commensal micro-organism drives the generation and function of Treg cells which control excessive NF-κB activation in vivo. These cellular interactions provide the basis for a more complete understanding of the commensal-host-pathogen trilogue that contribute to host homeostatic mechanisms underpinning protection against aberrant activation of the innate immune system in response to a translocating pathogen or systemic LPS.
The normal response to infection is rapid and effective clearance of pathogenic microbes. However, this immune response may occasionally cause collateral inflammatory damage to host tissue and in severe cases, such as systemic sepsis, results in organ failure. Various cellular mechanisms, including regulatory T cells, protect against aggressive immune responses. However, environmental agents which promote regulatory T cells are not well understood. We and others have previously shown that non-pathogenic or commensal micro-organisms can protect the host from aberrant pro-inflammatory activity within the gut, but the influence of these microbes on regulatory T cells in the context of systemic infection has not been examined. In this study, we demonstrate that consumption of a single commensal bacterium induces regulatory T cells in vivo which protect the host from pathogen-induced inflammatory responses by limiting activation of the pro-inflammatory transcription factor NF-κB via the toll-like receptor 4 (TLR-4) pathway. This report conclusively demonstrates a cellular and molecular basis for the commensal-host-pathogen trilogue resulting in enhanced protection from systemic infection whilst limiting pro-inflammatory damage mediated by activation of the innate immune system.
Citation: O'Mahony C, Scully P, O'Mahony D, Murphy S, O'Brien F, Lyons A, et al. (2008) Commensal-Induced Regulatory T Cells Mediate Protection against Pathogen-Stimulated NF-κB Activation. PLoS Pathog 4(8): e1000112. https://doi.org/10.1371/journal.ppat.1000112
Editor: Frederick M. Ausubel, Massachusetts General Hospital, United States of America
Received: November 27, 2007; Accepted: June 30, 2008; Published: August 1, 2008
Copyright: © 2008 O'Mahony et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was supported in part by Alimentary Health Ltd., Science Foundation Ireland in the form of a centre grant (Alimentary Pharmabiotic Centre), by the Health Research Board (HRB) of Ireland, and the Higher Education Authority (HEA) of Ireland.
Competing interests: The authors are affiliated with a multi-departmental university campus-based research company (Alimentary Health Ltd.), which investigates host-flora interactions and the therapeutic manipulation of these interactions in various human and animal disorders. The content of this article was neither influenced nor constrained by this fact.
Mechanisms of host protection by commensal organisms against infection vary depending on the nature of the pathogenic challenge. They range from mutual competition for nutrients and for microbial niches, to the production of specific anti-microbial peptides ,. In addition, there is emerging evidence for engagement of host immune responses by commensal organisms ,.
The host response to infection is characterised by innate and acquired cellular and humoral immune reactions, designed to limit spread of the offending organism and to restore organ homeostasis. However, to limit the aggressiveness of collateral damage to host tissues, a range of regulatory constraints may be activated. Regulatory T cells (Treg) serve one such mechanism . These are derived from the thymus but may also be induced in peripheral organs, including the gut mucosa ,. CD103+ dendritic cells within the mucosa are largely responsible for the conversion of Tregs which is a TGF-β and retinoic acid dependent process ,. The gastrointestinal specific environmental factors that contribute to dendritic cell conversion of Tregs is likely due in part to the presence of large numbers of commensal microbes. For example, encounter with specific experimental microbes within the murine gut, has been shown to drive the development of mucosal Tregs which is associated with attenuation of inflammation in a murine model of colitis . However, it is unclear whether enhancement of Treg activity by commensal organisms contributes to protection of the host from mucosal damage and systemic inflammation associated with infection by invasive pathogens.
Innate pro-inflammatory signalling in response to microbial exposure is mediated by activation of transcription factors, such as NF-κB, resulting in the transcription of a battery of effector molecules contributing to host defence and inflammation . A number of bacterial products have been identified which directly block activation of the NF-κB pathway in epithelial cells via a range of novel mechanisms including the blockade of Iκ-B poly-ubiquination by non-pathogenic Salmonella strains  or the enhancement of NF-κB export from the nucleus by Bacteroides thetaiotaomicron . However, these molecular events are likely to be restricted to the gastrointestinal mucosa where direct interactions with these bacterial organisms takes place. The cellular mechanisms permitting prokaryotic modulation of NF-κB activation following infection in cells outside the gastrointestinal tract is less clear.
The purpose of the present study was: (a) to determine if bacterial signalling from the lumen of the murine gut after feeding with a well characterised commensal/probiotic could impact in vivo activation of the pro-inflammatory transcription factor NF-κB following infection thereby limiting infection-associated inflammatory injury; (b) examine the mechanism of such protective regulation by assessing Treg cellular activity in probiotic-fed mice and by adoptive transfer of T cells into naïve non-fed animals. The results show that the putative probiotic/commensal organism drives Treg activity which limits the pro-inflammatory response to invasive salmonella infection via down-regulation of NF-κB activation.
Impact of B. infantis on the pro-inflammatory response to S. typhimurium
Mice consuming B. infantis were protected from the effects of infection with S. typhimurium. Biophotonic imaging of in vivo NF-κB activation illustrated a significant difference just four hours following infection (Figure 1A). B. infantis-fed animals exhibited a less pronounced activation of the in vivo NF-κB response compared to the NF-κB response to infection in placebo-fed controls. This suppressed pro-inflammatory response persisted for the remainder of the study period (Figure 1B). Murine clinical scores were not significantly different until 7 days after the initial infection at which stage B. infantis-fed animals were significantly better that placebo-fed controls (Figure 2A) Similarly, systemic pathogen numbers were not different between the groups until 6 days after infection (Figure 2B). Therefore, B. infantis attenuation of NF-κB activation in vivo precedes a reduction in S. typhimurium disease severity and systemic translocation.
(A) A representative in vivo image illustrates that NF-κB activation in NF-κBlux transgenic mice four hours following S. typhimurium infection is attenuated when an animal is pre-fed B. infantis; (B) In vivo NF-κB activation in B. infantis-fed animals was significant reduced compared to NF-κB activation in placebo-fed controls (n = 6/group). *p<0.05 versus placebo.
(A) Macroscopic clinical scoring of mice infected with S. typhimurium reveals a significant reduction in B. infantis pre-fed mice disease symptoms 8 days following initial infection (n = 10/group); (B) S. typhimurium numbers were reduced in the spleens and livers of B. infantis fed mice 6 days following infection (n = 18/group). *p<0.05 versus placebo.
B. infantis reduces the in vivo NF-κB response to LPS
In agreement with the results above suggesting a systemic anti-inflammatory effect of B. infantis consumption on S. typhimurium-induced inflammatory damage, in vivo imaging of the pro-inflammatory transcription factor NF-κB in response to LPS alone demonstrated significantly less activity in mice-fed B. infantis four hours after LPS injection (Figure 3A). In order to identify the sites at which NF-κB activity was being suppressed, we removed the small intestine, large intestine, liver and spleen from each animal and quantified NF-kB activity for each organ individually (Figure 3B). NF-kB activation within the small intestine, liver and spleen (but not the colon) was significantly reduced in B. infantis-fed animals (Figure 3C).
(A) Whole body imaging of NF-κBlux mice 4 hours following LPS injection reveals suppressed NF-κB activation in the B. infantis-fed animals. (B) Organs were removed for imaging purposes and a representative image is illustrated. (C) The mean increase in NF-κB activation following i.p. injection of LPS is significantly less in the ileum, spleen and liver of B. infantis-fed mice. *p<0.05 versus placebo, n = 5/group.
B. infantis consumption reduces pro-inflammatory cytokine secretion
In order to further characterise the impact of NF-κB suppression on the host inflammatory response, cytokine production by isolated Peyer's patch and spleen-derived cells was assessed, in vitro, following anti-CD3/CD28 stimulation (lymphocyte response) or LPS stimulation (innate TLR-4 response) immediately prior to S. typhimurium infection (Day 0) or four days (Day 4) after infection.
CD3/CD28 stimulation of Peyer's patch cells resulted in secretion of IFN-γ, TNF-α and IL-10 with no differences noted between placebo-fed controls or B. infantis-fed test animals prior to Salmonella infection (Figure 4A). However, four days of S. typhimurium infection was associated with enhanced release of IFN-γ, TNF-α and IL-10 by anti-CD3/CD28 stimulated Peyer's patch cells in placebo-fed animals but not in animals consuming B. infantis. In vitro stimulation of Peyer's patch cells with LPS yielded cytokine responses below the assay detection limit and were not examined further (results not shown).
Cytokine release by isolated cells was examined immediately prior to S. typhimurium infection (Day 0) or four days (Day 4) after infection. (A) In vitro cytokine production by anti-CD3/CD28 stimulated Peyer's patch cells is significantly reduced in S. typhimurium infected mice when fed B. infantis with no differences being observed prior to infection; (B) In vitro IFN-γ and IL-10 production by anti-CD3/CD28 stimulated spleenocytes is significantly increased in placebo-fed animals following S. typhimurium infection. However, this increase was not observed in animals consuming B. infantis. TNF-α levels were similar for the two groups; (C) LPS stimulated splenocytes released comparable amounts of cytokine from the two groups of animals prior to infection but four days following Salmonella translocation, LPS stimulated TNF-α, IL-6 and MCP-1 release was significantly less in the B. infantis-fed animals. *p<0.05 versus placebo, n = 8/group at each timepoint.
CD3/CD28 stimulation of splenocytes resulted in secretion of IFN-γ, TNF-α and IL-10 with low levels of IL-6 and MCP-1 (Figure 4B). In agreement with the Peyer's patch results, no differences in the cytokine secretion patterns were noted for in vitro stimulated splenocytes from placebo or B. infantis treated mice prior to infection. However, the anti-CD3/CD28 stimulated IFN-γ and IL-10 response was significantly attenuated following Salmonella infection in the B. infantis-fed animals. LPS stimulated splenocytes released comparable amounts of cytokine from the two groups of animals prior to infection but four days following Salmonella translocation, LPS stimulated TNF-α, IL-6 and MCP-1 release was significantly less in the B. infantis-fed animals (Figure 4C).
Dendritic cell CD80 expression is altered by B. infantis consumption
Presentation of antigen by dendritic cells to naïve T cells requires the expression of co-stimulatory molecules such as CD80 for effective maturation and clonal expansion of the interacting T cells. We examined the percentage of mature dendritic cells (CD11c+MHCII+) expressing CD80 in both the Peyer's patch and spleen of placebo and B. infantis-fed animals. Surprisingly, fewer Peyer's patch dendritic cells co-express CD80 when isolated from B. infantis-fed animals (Figure 5A). Dendritic cell CD80 expression increases in the Peyer's patches of all Salmonella infected animals but remains significantly less in the B. infantis-fed mice. Splenocyte dendritic cell CD80 expression is similar in both groups of un-infected mice but is significantly up-regulated with Salmonella infection only in the placebo group (Figure 5B).
(A) The percentage of CD11c+MHC II+ mature dendritic cells staining positive for the co-stimulatory molecule CD80 are reduced in the Peyer's patch of B. infantis-fed mice prior to and during S. typhimurium infection. (B) Splenocyte dendritic cell CD80 expression is similar in both groups of un-infected mice but is significantly up-regulated with Salmonella infection only in the placebo group. *p<0.05 versus placebo, n = 6–9 animals per group per timepoint.
B. infantis consumption is associated with increased numbers of T regulatory cells
The percentage of CD4+ T cells expressing the α chain of the IL-2 receptor, CD25, was examined in both Peyer's patch and spleen of un-infected and Salmonella infected animals. We noted a significant increase in the percentage of CD4+ cells co-expressing CD25 in the Peyer's patch of animals fed B. infantis, particularly following Salmonella infection (Figure 6A). A statistical significant inverse correlation was noted between the percentage of CD80+ activated dendritic cells and CD4+CD25+ T cells within the Peyer's patch suggesting a link between dendritic cell co-stimulatory molecule expression and T regulatory cell induction (r2 = 0.419, p = 0.01). This does not prove a causal relationship but simply implies that these cellular events may both be associated with bifidobacterial consumption.
(A) There is a significant increase in the percentage of CD4+ cells co-expressing CD25 in the Peyer's patch of animals fed B. infantis, particularly following Salmonella infection; (B) There are also significantly more CD4+CD25+ cells in the spleen of animals fed B. infantis; (C) A representative flow cytometry dot-plot illustrates that the majority of the CD25+ cells within the spleen also stain positive for Foxp3 which is graphed for B. infantis-fed animals in (D); (E) CD4+CD25+ T cells suppressed proliferation of naïve CFSE labelled CD4+ cells while depletion of the CD25+ subset cells removed the suppressive effect. *p<0.05 versus placebo.
There are also significantly more CD4+CD25+ cells in the spleen of animals fed B. infantis (Figure 6B). The majority (>75%) of the spleen-derived CD4+CD25+ T cells also stained positive for the Treg transcription factor Foxp3 (Figure 6C & 6D). Finally, when these T cells were isolated and examined in vitro, the CD4+CD25+ T cells suppressed proliferation of naïve CFSE labelled CD4 cells while depletion of the CD25+ subset cells removed the suppressive effect (Figure 6E).
CD4+CD25+ T cell adoptive transfer reduces in vivo NF-κB activation
In order to examine the hypothesis that NF-κB suppression is mediated by bifidobacterial induction of Tregs, we isolated CD4+ T cells from placebo or B. infantis-fed animals and adoptively transferred these to naïve animals. Following LPS injection, NF-κB activation was significantly less in animals that received CD4+ T cells from B. infantis-fed mice compared to animals that received CD4+ T cells from placebo-fed mice (Figure 7A & 7B). Depletion of the CD25+ subset from the T cell population removed the suppressive effect while adoptive transfer of CD25+ cells alone was sufficient to reduce NF-κB activation in situ and release of TNF-α from cultured splenocytes (Figure 7C & 7D).
(A) In vivo adoptive transfer of CD4+ NF-κB−/− T cells from B. infantis-fed animals resulted in significant attenuation of NF-κB activity following i.p. LPS administration in NF-κBlux+/+ animals compared to mice that received T cells from placebo-fed controls (n = 6/group); (B) A subsequent study performed an identical adoptive transfer experiment except that nuclear NF-κB activation was measured using an ELISA system instead of biophotonic imaging - identical results were observed in that CD4+ T cells from B. infantis-fed animals significantly reduced LPS stimulated NF-κB activation (n = 5/group); (C) Removal of the CD25+ subpopulation from the CD4+ cells resulted in loss of the NF-kB suppressive activity while adoptive transfer of the CD25+ population alone replicated the CD4+ suppressive effect; (D) Similarily, the reduction in TNF-α secretion associated with CD4+ T cell transfer was lost when CD25+ were depleted but was replicated with transfer of CD25+ cells alone (n = 5/group). *p<0.05 versus placebo T cells; **p<0.05 versus CD4 T cells.
This report illustrates at a cellular and molecular level the impact of the commensal microbiota on host immune defence and immune homeostasis. The deliberate consumption of one commensal organism, Bifidobacterium infantis 35624, resulted in the induction of Treg cells which protected the host from excessive inflammation during the course of infection as evidenced by reduced pro-inflammatory cytokine production, reduced T cell proliferation, reduced dendritic cell co-stimulatory molecule expression and attenuation of NF-κB activation. The role of Treg cells in this biological process was conclusively demonstrated by the adoptive transfer of CD4+CD25+ T cells into naïve mice which was sufficient to suppress NF-κB activation in response to LPS injection.
Treg cells have been well described as suppressors of auto-reactive T cells , and suppress inflammatory disease in a wide range of murine models including experimental autoimmune encephalomyelitis , inflammatory bowel disease , bacterial-induced colitis , collagen-induced arthritis , type I diabetes , airway eosinophilic inflammation , graft-vs-host disease  and organ transplantation . Similarly, supplementation of the microbiota with certain commensal micro-organisms has also shown anti-inflammatory effects in a number of these models –. It is tempting to speculate that induction of Treg cells by the commensal microbiota could be partly responsible for the observed anti-inflammatory activity in these model systems. However, the role of commensal bacteria in controlling the pro-inflammatory response associated with infection is less clear. Indeed, the activity of Treg cells in the models above is primarily mediated by suppression of antigen specific immune responses while our studies demonstrate an effect on innate immune activation, in particular activation through the TLR-4 pathway. It has been recently suggested that CD4+CD25+ T cells induce an alternative activation pathway in monocytes associated with a diminished capacity to respond to LPS which supports the findings of this study ,.
The host cellular mechanisms underpinning induction of Treg cells by the commensal microbiota was not examined in this study but is hypothesised to be mediated in part by dendritic cells. Following encounter with pathogenic or commensal microbes, dendritic cells provide instructive signals that influence T cell differentiation into Th1, Th2 or regulatory phenotypes ,. Multiple reports implicate dendritic cells in the induction of tolerance and regulatory cells to the commensal microbiota . In vitro co-incubation of human mesenteric lymph node derived dendritic cells with B. infantis resulted in the secretion of IL-10 and TGF-β, but not TNF-α or IL-12 . Both IL-10 and TGF-β are important cytokines in directing naïve T cell maturation down a regulatory pathway. In addition, in vitro co-incubation of monocyte derived dendritic cells with certain commensal lactobacilli strains have been shown to drive the in vitro generation of IL-10 producing T cells which inhibit bystander T cell proliferation .
Not all commensal micro-organisms may be equally effective in driving T regulatory cell activity. Co-incubation of a panel of commensal bacteria with peripheral blood mononuclear cells (PBMCs) in vitro resulted in varying amounts of IL-10 production suggesting that strain specific characteristics, as yet largely undefined, drive regulatory cytokine production . Commensal-induced protection from infection may also involve additional strain-specific mechanisms of action including the production of selective anti-microbial compounds . The relative importance of microbe-microbe and microbe-host interactions in protecting the host from infection is likely to also depend on the nature of the infectious organism. However, the mechanism underpinning the suppressed pro-inflammatory response to a translocating microbe described in this study strongly implicate Tregs as modulation of the host pro-inflammatory response precedes the difference in systemic salmonella recovery. In addition, LPS injection models systemic infection with a gram negative pathogen and suppression of the host response to LPS alone can not be explained by other mechanisms such as competition within the intestine or activation of pathogen-specific effector T cells.
This report clearly demonstrates that activation of the host innate pro-inflammatory pathways to a translocating infectious agent, or systemic LPS, can be influenced by the commensal microbiota via the induction of Treg cells. NF-κB is a key transcription factor that is central to the observed anti-inflammatory effect and improved regulation of NF-κB is an important therapeutic target in a wide range of pro-inflammatory states, including sepsis . This report supports the clinical evaluation of appropriately selected probiotic/commensal micro-organisms for the promotion of CD4+CD25+Foxp3+ T cells in vivo in order to control the innate inflammatory cascade to translocating microbes.
Materials and Methods
Balb/c mice were obtained from Charles River Laboratories (Bicester, UK) and bred in-house for bifidobacterial feeding and salmonella infection studies. NF-kBlux transgenic mice on a C57BL/6J-CBA/J background were obtained from Charles River Laboratories (Wilmington, USA) and bred in-house. Mice were housed under barrier maintained conditions within the biological services unit, University College Cork (UCC). All animal experiments were approved by the UCC animal ethics committee and experimental procedures were conducted under appropriate license from the Irish government.
Bifidobacterium infantis 35624 (B. infantis) was isolated from healthy human gastrointestinal tissue and its use as a probiotic organism has been previously reported ,. B. infantis was routinely cultured anaerobically for 48 hours in deMann, Rogosa and Sharpe medium, MRS, (Oxoid, Basingstoke, UK) supplemented with 0.05% cysteine (Sigma, Dublin, Ireland). Salmonella typhimurium UK1 (S. typhimurium) was provided by Roy Curtis (Washington University, US) and was routinely cultured aerobically at 37°C for 24 hours in tryptic soya broth (Oxoid).
Animal model feeding studies
B. infantis was administered to all animals as a freeze-dried powder reconstituted in water at approximately 1×109 colony forming units/day/animal. Mice consumed the commensal micro-organism in their drinking water ad libitum for at least 3 weeks prior to salmonella infection. Challenge with S. typhimurium was performed as described by Wilems-Riesenberg et al ,. Briefly, S. typhimurium was grown overnight, pelleted and resuspended in buffered saline gelatin (0.85% NaCl, 0.01% gelatin and 2.2 mM KH2PO4). Inoculation with Salmonella was performed by injecting 20 µl of a single inoculum of the Salmonella suspension behind the murine incisors with a micropipette tip in a flexible film isolator. A dose of 1×106 S. typhimurium viable cells was chosen as the optimal dose for these studies as higher doses did not result in increased recovery of viable cells from the murine liver and spleen while lower doses did not yield reproducible or consistent bacterial counts from systemic sites . Animals were monitored for disease progression using a clinical scoring scale. This scale scored animals from 0 (no disease) to 7 (severe disease) and is illustrated in Table 1.
Salmonella titres were calculated in liver and spleen using quantitative real-time Polymerase Chain Reaction (qPCR). Briefly, liver and spleen samples were transferred to sterile stomacher bags and mixed with 1X PBS (Gibco BRL, UK) and homogenised using mechanical means. Samples were stored at-20°C until analysis. DNA extractions were performed using the Qiagen DNAeasy Tissue Kit (Qiagen,West Sussex, UK) according to manufacturers instructions. Isolated DNA concentrations were ascertained using the Nanodrop (Thermo Scientific) and standardised to 20 ng DNA per reaction. LightCycler Real-time PCR was used to quantify Salmonella genomic DNA concentrations using the following primers INVA2_R: 5′-TGT CCT CCG CTC TGT CTA CTT -3′ INVA2_L: 5′-ATC AAC AAT GCG GGG ATC T -3′ (76 bp product), and Probe library #9 (Roche Diagnostics). All primers were synthesized by MWG Biotech, (Ebersberg Germany). PCR amplifications were carried out in glass capillaries (Roche Diagnostics) in a total final volume of 20 µl using a LightCycler (Roche Diagnostics). A standard curve was generated by adding DNA from 10 fold dilution series of purified Salmonella genomic DNA. This was used to calculate Salmonella concentration. The LightCycler software identified the Ct (threshold cycle number) values and the concentrations of Salmonella were calculated by comparing Ct values to the crossing point values of the linear regression line of the standard curve.
In vivo assessment of NF-κB signalling
In vivo imaging of NF-kBlux transgenic mice were performed by firstly anaesthetizing the mice with isoflurane (Inhalation Anaesthetic, Abbot Laboratories Ltd., Kent, UK). D-luciferin (120 mg/kg; Biothema AB, Handen, Sweden) dissolved in 200 ul PBS, pH 7.8, was injected i.p. Immediately afterwards the mice were placed in a ventral recumbent position in a light-sealed chamber in the In Vivo Imaging System (IVIS) chamber (Xenogen, Alameda, USA) and imaged continuously for 5 minutes with a medium sensitivity setting starting 2 minutes after the injection of D-luciferin. A reference black and white image of the animal was taken in low light conditions then a sensitive cooled charge-coupled device camera collected the photons emitted. Photons were quantified using Living Image software (Xenogen) and the luciferase activity quantified as the amount of light emitted per second per cm2 from the animal/organs. The pseudo-colored images represent light intensity (red is the strongest and violet is the weakest).
Individual organs to be imaged were excised from the mice 5 minutes following D-luciferin administration. Organs were placed in a culture dish and immediately imaged, again with an acquisition integration time of 5 minutes. Organs examined were the spleen, liver, small intestine and colon.
In vitro culture and cytokine measurement
Spleens were aseptically removed from all animals and a single cell suspension generated using mechanical means. In addition, the small intestine of mice were removed and the lymphoid follicles of the Peyer's patches were carefully dissected from the intestinal serosal side with curved scissors and collected into 5 ml of PBS containing 1 mM EDTA and collagenase (Sigma). Following incubation in a shaking oven at 37°C for 20 mins, the collected patches were placed between two sterile glass slides and crushed. This cell suspension was centrifuged (100 g×10 min) and the pellet was resuspended and diluted in Dulbecco's modified eagle medium (DMEM). Single cell suspensions were seeded, in duplicate, in 24 well tissue culture plates (Sarstedt, Newton, USA) at 1×106 cells per well. Single cell suspensions were stimulated for 72 hours with anti-CD3 and anti-CD28 antibodies (BD Biosciences, Oxford, UK), LPS (Sigma) or remained non-stimulated to assess background cytokine secretion. Following a 72-hour incubation period (@37°C and 5% CO2 humidified atmosphere) all supernatants were harvested for cytokine analysis. These were aliquoted and stored at −70°C for analysis of cytokine production in batches. IL-6, IL-10, IL-12, MCP-1, TNF-α and IFN-γ levels were quantified using cytometric bead arrays (BD). Cytokine levels were measured using a BD FacsCaliber flow cytometer and analysis was carried out using the BD CellQuest software and BD CBA Software.
CD4 T cell proliferation was measured using the CellTrace™ CFSE Cell Proliferation Kit (Invitrogen). Briefly, CD4+ T Cells were positively selected (>98% purity) from spleens using CD4 MicroBeads (Miltenyi Biotech, Bergisch Gladbach, Germany) and an autoMACS separator. These cells were labeled with CFSE and incubated in vitro for three days with anti-CD3 and anti-CD28 stimulation (BD). Concurrently, CD4+ T cells were isolated from B. infantis-fed mice as outlined above and subdivided into CD4+CD25+ and CD4+CD25− populations using microbeads (Miltenyi). These cells were not CFSE labeled and were co-incubated with the labeled cells for the three day stimulation period. Lymphocyte proliferation was measured by flow cytometry.
Single cell suspensions from the Peyer's patch and spleens of mice were generated as outlined above. Monoclonal antibodies to CD3, CD4, CD11c, CD25, CD80 and MHC II (BD) were used to label cells for T cell subset analysis (CD3, CD4 and CD25) and dendritic cell co-stimulatory molecule expression (CD11c, MHC II and CD80). Antibodies to the transcription factor Foxp3 (eBioscience, San Diego, USA) were used to label permeabilised cells in representative experiments. Cellular phenotypes were measured using a BD FacsCaliber flow cytometer and analysis was carried out using the BD CellQuest software.
Impact of CD4+CD25+ T cell adoptive transfer on NF-κB activation
In vivo assessment of NF-κB activation was determined following feeding of wildtype (NFkB−/−) mice with either B. infantis or placebo for three weeks. The spleens were removed and CD4+ T Cells were positively selected (>98% purity) using the method outlined above. Adoptive transfer of 1×106 CD4+ T cells/ml into NF-kBlux+/+ transgenic mice (n = 6/grp) was performed by i.p. injection. 8 days later 3 mg/kg LPS (Sigma) was injected i.p. and NF-κB measurements taken after 4 hours. In vivo images were captured by the IVIS in the same manner as described above.
In order to determine the CD4+ T cell subset responsible for mediating this effect, CD4 T cells from B. infantis-fed animals were further isolated into CD4+/CD25+ and CD4+/CD25− subpopulations as per manufactures protocol (Miltenyi Biotech, Bergisch Gladbach, Germany). Adoptive transfer of 1.5×105 CD4+/CD25+ T cells/ml or 8.5×105 CD4+/CD25− T cells/ml into naïve mice (n = 5/grp) was performed by i.p. injection. 8 days later 3 mg/kg LPS (Sigma) was injected i.p. and animals were sacrificed after 4 hours and tissues harvested. Intestinal NF-κB p65 activation was measured in nuclear extracts using an NF-κB p65 ELISA-based transcription factor assay kit (TransAM Assay, Active Motif, Germany) according to the manufacturer's protocol. TNF-α release from LPS stimulated splenocytes was measured using flow cytometry as outlined above.
Conceived and designed the experiments: CO JM BK FS LO. Performed the experiments: CO PS DO SM FO AL GS JM LO. Analyzed the data: CO PS DO SM AL GS JM LO. Contributed reagents/materials/analysis tools: LO. Wrote the paper: CO JM BK FS LO.
- 1. Servin AL (2004) Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens. FEMS Microbiol Rev 28: 405–40.
- 2. Corr SC, Li Y, Riedel CU, O'Toole PW, Hill C, et al. (2007) Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118. Proc Natl Acad Sci U S A 104: 7617–21.
- 3. Gill HS (2003) Probiotics to enhance anti-infective defences in the gastrointestinal tract. Best Pract Res Clin Gastroenterol 17: 755–73.
- 4. Kitano H, Oda K (2006) Robustness trade-offs and host-microbial symbiosis in the immune system. Mol Syst Biol 2: 2006.0022.
- 5. Belkaid Y, Rouse BT (2005) Natural regulatory T cells in infectious disease. Nature Immunol 6: 353–360.
- 6. Karim M, Kingsley CI, Bushell AR, Sawitzki BS, Wood KJ (2004) Alloantigen-induced CD25+CD4+ regulatory T cells can develop in vivo from CD25−CD4+ precursors in a thymus-independent process. J Immunol 172: 923–928.
- 7. Chen W, Jin W, Hardegen N, Lei KJ, Li L, et al. (2003) Conversion of peripheral CD4+CD25− naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3. J Exp Med 198: 1875–1886.
- 8. Sun CM, Hall JA, Blank RB, Bouladoux N, Oukka M, et al. (2007) Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J Exp Med 204: 1775–1785.
- 9. Coombes JL, Siddiqui KR, Arancibia-Cárcamo CV, Hall J, Sun CM, et al. (2007) A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J Exp Med 204: 1757–64.
- 10. Di Giacinto C, Marinaro M, Sanchez M, Strober W, Boirivant M (2005) Probiotics Ameliorate Recurrent Th1-Mediated Murine Colitis by Inducing IL-10 and IL-10-Dependent TGF-β Bearing Regulatory Cells. J Immunol 174: 3237–3246.
- 11. Collier-Hyams LS, Neish AS (2005) Innate immune relationship between commensal flora and the mammalian intestinal epithelium. Cell Mol Life Sci 62: 1339–1348.
- 12. Collier-Hyams LS, Zeng H, Sun J, Tomlinson AD, Bao ZQ, et al. (2002) Cutting edge: Salmonella AvrA effector inhibits the key proinflammatory, anti-apoptotic NF-kappa B pathway. J Immunol 2002 169: 2846–2850.
- 13. Kelly D, Campbell JI, King TP, Grant G, Jansson EA, et al. (2004) Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA. Nat Immunol 5: 104–112.
- 14. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor +-chains (CD25): breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155: 1151–1164.
- 15. Itoh M, Takahashi T, Sakaguchi N, Kuniyasu Y, Shimizu J, et al. (1999) Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J Immunol 162: 5317–5326.
- 16. Kohm AP, Carpentier PA, Anger HA, Miller SD (2002) Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J Immunol 169: 4712–4716.
- 17. Mottet C, Uhlig HH, Powrie F (2003) Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells. J Immunol 170: 3939–3943.
- 18. Kullberg MC, Jankovic D, Gorelick PL, Caspar P, Letterio JJ, et al. (2002) Bacteria-triggered CD4(+) T regulatory cells suppress Helicobacter hepaticus-induced colitis. J Exp Med 196: 505–515.
- 19. Morgan ME, Sutmuller RP, Witteveen HJ, van Duivenvoorde LM, Zanelli E, et al. (2003) CD25+ cell depletion hastens the onset of severe disease in collagen induced arthritis. Arthritis Rheum 48: 1452–1460.
- 20. Salomon B, Lenschow DJ, Rhee L, Ashourian N, Singh B, et al. (2000) B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 12: 431–440.
- 21. Jaffar Z, Sivakuru T, Roberts K (2004) CD4+CD25+ T cells regulate airway eosinophilic inflammation by modulating the Th2 cell phenotype. J Immunol 172: 3842–3849.
- 22. Taylor PA, Lees CJ, Blazar BR (2002) The infusion of ex vivo activated and expanded CD4+CD25+ immune regulatory cells inhibits graft-versus-host disease lethality. Blood 99: 3493–3499.
- 23. van Maurik A, Herber M, Wood KJ, Jones ND (2002) Cutting edge: CD4+CD25+ alloantigen-specific immunoregulatory cells that can prevent CD8+ T cell-mediated graft rejection: implications for anti-CD154 immunotherapy. J Immunol 169: 5401–5404.
- 24. Sheil B, McCarthy J, O'Mahony L, Bennett MW, Ryan P, et al. (2004) Is the mucosal route of administration essential for probiotic function? Subcutaneous administration is associated with attenuation of murine colitis and arthritis. Gut 53: 694–700.
- 25. Forsythe P, Inman MD, Bienenstock J (2007) Oral treatment with live Lactobacillus reuteri inhibits the allergic airway response in mice. Am J Respir Crit Care Med 175: 561–569.
- 26. McCarthy J, O'Mahony L, O'Callaghan L, Sheil B, Vaughan EE, et al. (2003) Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance. Gut 52: 975–980.
- 27. O'Mahony L, Feeney M, O'Halloran S, Murphy L, Kiely B, et al. (2001) Probiotic impact on microbial flora, inflammation and tumour development in IL-10 knockout mice. Alim Pharmacol Ther 15: 1219–1225.
- 28. Tiemessen MM, Jagger AL, Evans HG, van Herwijnen MJ, John S, Taams LS (2007) CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages. Proc Natl Acad Sci USA 104: 19446–19451.
- 29. Taams LS, van Amelsfort JM, Tiemessen MM, Jacobs KM, de Jong EC, et al. (2005) Modulation of monocyte/macrophage function by human CD4+CD25+ regulatory T cells. Hum Immunol 66: 222–230.
- 30. Young JW, Merad M, Hart DN (2007) Dendritic cells in transplantation and immune-based therapies. Biol Blood Marrow Transplant 13: 23–32.
- 31. Amati L, Pepe M, Passeri ME, Mastronardi ML, Jirillo E, et al. (2006) Toll-like receptor signaling mechanisms involved in dendritic cell activation: potential therapeutic control of T cell polarization. Curr Pharm Des 12: 4247–4254.
- 32. Kelsall BL (2008) Innate and adaptive mechanisms to control pathological intestinal inflammation. J Pathol 214: 242–259.
- 33. O'Mahony L, O'Callaghan L, McCarthy J, Shilling D, Scully P, et al. (2006) Differential cytokine response from dendritic cells to commensal and pathogenic bacteria in different lymphoid compartments in humans. Am J Physiol Gastrointest Liver Physiol 290: G839–G845.
- 34. Smits HH, Engering A, Van der Kleij D, De Jong EC, Schipper K, et al. (2005) Selective probiotic bacteria induce IL-10–producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell–specific intercellular adhesion molecule 3–grabbing nonintegrin. J Allergy Clin Immunol 115: 1260–1267.
- 35. Niers LEM, Timmermanw HM, Rijkersw GT, van Bleekw GM, van Udenw NOP, et al. (2005) Identification of strong interleukin-10 inducing lactic acid bacteria which down-regulate T helper type 2 cytokines. Clin Exp Allergy 35: 1481–1489.
- 36. Hawiger J (2001) Innate immunity and inflammation: a transcriptional paradigm. Immunol Res 23: 99–109.
- 37. O'Mahony L, McCarthy J, Kelly P, Hurley G, Luo F, et al. (2005) Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 128: 541–551.
- 38. Whorwell PJ, Altringer L, Morel J, Bond Y, Charbonneau D, et al. (2006) Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am J Gastroenterol 101: 1581–1590.
- 39. Riesenberg-Wilmes MR, Bearson B, Foster JW, Curtis R (1996) Role of the acid tolerance response in virulence of Salmonella typhimurium. Infect Immun 64: 1085–1092.
- 40. Riesenberg-Wilmes MR, Bearson B, Foster JW, Curtis R (1997) An altered rpoS allele contributes to the avirulence of Salmonella typhimurium LT2. Infect Immun 65: 203–210.
- 41. O'Mahony L, Kenneally P, O'Donoghue M, Kiely B, Shanahan F, Collins JK (2002) Multi-organism comparison of probiotic performance in a murine model of Salmonella typhimurimum infection. Gastroenterology 122: A458–A458.